| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
IGM Biosciences Inc (NASDAQ: IGMS)
IGMS Technical Analysis
5
| As on 9th Jun 2023 IGMS STOCK Price closed @ 10.62 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 19.57 & Strong Sell for SHORT-TERM with Stoploss of 20.54 we also expect STOCK to react on Following IMPORTANT LEVELS. |
IGMSSTOCK Price
| Open | 11.11 | Change | Price | % |
| High | 11.11 | 1 Day | -0.47 | -4.24 |
| Low | 10.59 | 1 Week | -1.43 | -11.87 |
| Close | 10.62 | 1 Month | -0.18 | -1.67 |
| Volume | 137811 | 1 Year | -17.66 | -62.45 |
| 52 Week High 29.84 | 52 Week Low 9.98 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| IGMS Daily Charts |
IGMS Intraday Charts |
Whats New @ Bazaartrend |
IGMS Free Analysis |
|
|
IGMS Important Levels Intraday
| RESISTANCE | 11.62 |
| RESISTANCE | 11.30 |
| RESISTANCE | 11.10 |
| RESISTANCE | 10.90 |
| SUPPORT | 10.34 |
| SUPPORT | 10.14 |
| SUPPORT | 9.94 |
| SUPPORT | 9.62 |
IGMS Forecast May 2024
| 4th UP Forecast | 31.51 |
| 3rd UP Forecast | 24.81 |
| 2nd UP Forecast | 20.67 |
| 1st UP Forecast | 16.53 |
| 1st DOWN Forecast | 4.71 |
| 2nd DOWN Forecast | 0.57 |
| 3rd DOWN Forecast | -3.57 |
| 4th DOWN Forecast | -10.27 |
IGMS Weekly Forecast
| 4th UP Forecast | 18.17 |
| 3rd UP Forecast | 15.75 |
| 2nd UP Forecast | 14.25 |
| 1st UP Forecast | 12.76 |
| 1st DOWN Forecast | 8.48 |
| 2nd DOWN Forecast | 6.99 |
| 3rd DOWN Forecast | 5.49 |
| 4th DOWN Forecast | 3.07 |
IGMS Forecast2024
| 4th UP Forecast | 61.18 |
| 3rd UP Forecast | 44.97 |
| 2nd UP Forecast | 34.94 |
| 1st UP Forecast | 24.92 |
| 1st DOWN Forecast | -3.68 |
| 2nd DOWN Forecast | -13.7 |
| 3rd DOWN Forecast | -23.73 |
| 4th DOWN Forecast | -39.94 |
IGM Biosciences Inc ( NASDAQ USA Symbol : IGMS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
IGMS Business Profile
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of multiple diseases. Its lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 1 clinical trials to treat patients with relapsed/refractory B cell Non-Hodgkin's lymphoma (NHL). The company is also developing IGM-8444, an IgM antibody, which is in Phase 1 clinical trials for the treatment of patients with solid cancers and NHL; and IGM-7354, is a bispecific IgM antibody delivering interleukin-15 cytokines to PD-L1 expressing cells for use in the treatment of patients with solid and hematologic malignancies. It has a strategic research and license agreement with AbCellera to discover and develop IgM antibodies; and license agreement with AvantGen Inc. for various antibodies against the SARS-CoV-2 virus. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California. Address: 325 East Middlefield Road, Mountain View, CA, United States, 94043
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service